Halozyme share price
Web23 hours ago · Get a real-time Halozyme Therapeutics, Inc. (HALO) stock price quote with breaking news, financials, statistics, charts and more. WebAntares Pharma stock rockets after Halozyme buyout deal for a near-50% premium. MarketWatch. 06:00AM. Halozyme to Acquire Antares Pharma to Create a Specialty …
Halozyme share price
Did you know?
WebApr 10, 2024 · On Friday 04/07/2024 the closing price of the Halozyme Therapeutics Inc. share was $38.33 on NAS. Compared to the opening price on Friday 04/07/2024 on … WebMar 17, 2024 · The consensus estimate for Halozyme Therapeutics' current full-year earnings is $2.56 per share. SVB Leerink also issued estimates for Halozyme Therapeutics' Q1 2024 earnings at $0.78 EPS, Q2 2024 earnings at $0.90 EPS, Q3 2024 earnings at $0.94 EPS and Q4 2024 earnings at $0.92 EPS. Several other research firms also …
Web18 hours ago · About Price to Cash Flow. The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with ... WebJan 3, 2024 · For instance the Halozyme Therapeutics, Inc. (NASDAQ:HALO) share price is 219% higher than it was three years ago. That sort of return is as solid as granite. That sort of return is as solid as ...
WebGet Halozyme Therapeutics Inc (HALO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebApr 13, 2024 · The company has a market cap of $4.92 billion, a price-to-earnings ratio of 25.06, a price-to-earnings-growth ratio of 0.57 and a beta of 1.22. Halozyme Therapeutics, Inc. has a 12-month low of $32.83 and a 12-month high of $59.46. The company has a quick ratio of 4.88, a current ratio of 5.65 and a debt-to-equity ratio of 8.79.
WebApr 10, 2024 · Halozyme Therapeutics, Inc. Common Stock (HALO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebGet Halozyme Therapeutics Inc (HALO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. hoteis icapuiptg ancaWeb18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Halozyme Therapeutics (HALO) hoteis fortimWebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Halozyme Therapeutics Inc.’s P/E ratio is 25.63. hoteis friburgoWebAug 8, 2024 · It might be of some concern to shareholders to see the Halozyme Therapeutics, Inc. (NASDAQ:HALO) share price down 13% in the last month. But in stark contrast, the returns over the last half ... ptg businessWebApr 13, 2024 · Under the terms of the merger agreement, Halozyme will commence a cash tender offer to acquire all of the outstanding shares of Antares for $5.60 per share in cash. The transaction is not subject ... ptg asscpWebWells Fargo Adjusts Halozyme Therapeutics' Price Target to $55 From $65, Keeps Overweight Rating. MT Newswires. 03/16 10:01. SVB Securities Downgrades Halozyme … ptg asics